Gastrointestinal tumours 2
Invited discussant abstracts 144O and 145O
Date
20 Dec 2015Session
Gastrointestinal tumours 2Presenters
Kei MuroAuthors
K. MuroAuthor affiliations
- Clinical Oncology, Aichi Cancer Center Hospital, 464-8681 - Nagoya/JP
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
View the abstracts discussed:
- Comparison of efficacy and safety of paclitaxel and capecitabine followed by capecitabine as maintenance therapy versus cisplatin and capecitabine therapy for advanced gastric cancer: a multicentre, randomised, active-controlled phase III study
- Phase II study of AZD4547 in FGFR amplified tumours: gastroesophageal cancer (GC) cohort clinical and translational results
Resources from the same session
599 - Comparison of efficacy and safety of paclitaxel and capecitabine followed by capecitabine as maintenance therapy versus cisplatin and capecitabine therapy for advanced gastric cancer: a multicentre, randomised, active-controlled phase III study
Presenter: Xiaotian Zhang
Session: Gastrointestinal tumours 2
Resources:
Abstract
1096 - Phase II study of AZD4547 in FGFR amplified tumours: gastroesophageal cancer (GC) cohort clinical and translational results
Presenter: Elizabeth Smyth
Session: Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
1025 - RADIANT-4: Efficacy and safety of everolimus in advanced, nonfunctional neuroendocrine tumors (NET) of the lung or gastrointestinal (GI) tract
Presenter: James Yao
Session: Gastrointestinal tumours 2
Resources:
Abstract
Invited discussant abstract 134O
Presenter: Sun Young Rha
Session: Gastrointestinal tumours 2
Resources:
Slides
Webcast